Q1 2025 Earnings Call Transcript May 12, 2025 FibroGen, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $0.03. Operator: Good day and thank you for standing by.

May 7, 2025Lantheus Holdings, Inc. misses on earnings expectations. Reported EPS is $1.53 EPS, expectations were $1.68. Operator: Good morning. Welcome to the Lantheus First Quarter 2025 Conference ...

LMI will provide Lantheus with a commercial radiodiagnostic Alzheimer’s franchise, a talented team, and NEURACEQ, a globally approved F-18 PET imaging agent used to detect beta-amyloid plaques in ...

The solid cash conversion allows Telix to internally fund organic growth and flexibility to pursue acquisitions. We expect the company to reinvest the majority of earnings into R&D. We forecast ...

Macy Ringlein, a senior at Kearney Catholic High School, has worked part-time and volunteered at the World Theater while ...

When President Donald Trump named Robert F. Kennedy Jr. as his choice to lead ... published March 4 in the journal Cell Metabolism, used brain imaging to see whether consuming ultraprocessed ...

Medicines Discovery Catapult is driving national productivity in biotech and improving patients’ lives. Purposeful ...

In an article published in Genomic Psychiatry, researchers from Fudan University and Shanghai University of Traditional ...

This review explores the role of PET in imaging immune activation, particularly in oncology. 18F-FDG is widely used for assessing treatment response to immunotherapies and can demonstrate unique ...

MELBOURNE, Australia, May 5, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that its prostate cancer PET [1] imaging agent ...

Chinese researchers have made significant progress in developing positron emission tomography (PET) tracers that can ...